1. Home
  2. OVBC vs CHRS Comparison

OVBC vs CHRS Comparison

Compare OVBC & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

N/A

Current Price

$44.18

Market Cap

220.0M

Sector

Finance

ML Signal

N/A

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.14

Market Cap

177.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVBC
CHRS
Founded
1872
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.0M
177.7M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
OVBC
CHRS
Price
$44.18
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $5.51
AVG Volume (30 Days)
18.8K
★ 1.1M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
★ 2.22%
N/A
EPS Growth
42.67
★ 472.00
EPS
★ 1.53
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$73.08
Revenue Next Year
N/A
$30.94
P/E Ratio
$28.90
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$34.18
$1.09
52 Week High
$51.25
$2.62

Technical Indicators

Market Signals
Indicator
OVBC
CHRS
Relative Strength Index (RSI) 42.91 38.57
Support Level $44.33 N/A
Resistance Level $45.48 $1.53
Average True Range (ATR) 1.24 0.09
MACD -0.30 -0.02
Stochastic Oscillator 42.00 5.17

Price Performance

Historical Comparison
OVBC
CHRS

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

Share on Social Networks: